← Back to Search

Behavioral Activation (BA) for Opioid Use Disorder

N/A
Waitlist Available
Led By Julia Felton, PhD.
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at study completion; up to 24 weeks
Awards & highlights

Study Summary

This trial will help to support and train peer recovery coaches to help those with opioid use disorder to stay on their medications and improve their lives.

Eligible Conditions
  • Opioid Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at study completion; up to 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at study completion; up to 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Feasibility: percentage of patients who agree to participate in the intervention
MOUD Retention Rate
Secondary outcome measures
Intervention Acceptability: percentage of patients enrolled who attend ≥75% sessions
Intervention Fidelity: percentage of intervention components delivered as intended

Side effects data

From 2016 Phase 3 trial • 221 Patients • NCT01299766
5%
Death NOS
4%
Knee replacement
4%
Stroke
2%
bypass surgery
2%
Heart attack
2%
Pacemaker implanted
2%
COPD
2%
GI symptoms
1%
infection
1%
Breast cancer
1%
hypoglycemia
1%
Edema
1%
Fracture
1%
Broken shoulder
1%
Valve replacement
1%
Asthma Attack
1%
Prostate cancer
1%
colon cancer
1%
Blood clot
1%
pneumonia
1%
Hernia repair
1%
Seziure
1%
CHF
1%
aneurysm
1%
Depression
100%
80%
60%
40%
20%
0%
Study treatment Arm
Behavior Activation
Supportive Therapy (ST)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Peer-delivered Behavioral ActivationExperimental Treatment1 Intervention
Adults 18 years or older on MOUD or referred to MOUD will receive Behavioral Activation (BA) an evidence-based intervention (EBI) by trained Peer Recovery Coaches (PRC)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Activation (BA)
2014
Completed Phase 3
~350

Find a Location

Who is running the clinical trial?

University of Maryland, College ParkOTHER
154 Previous Clinical Trials
45,445 Total Patients Enrolled
Henry Ford Health SystemLead Sponsor
300 Previous Clinical Trials
2,100,005 Total Patients Enrolled
Julia Felton, PhD.Principal InvestigatorHenry Ford Health System

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many men and women are participating in this clinical trial?

"That is correct. The clinicaltrials.gov listing for this trial says that it was first posted on 10/20/2021 and last updated on 2/10/2022, meaning that the study is still actively recruiting patients. They are looking for 40 individuals total, across 1 location."

Answered by AI

Are there still opportunities for people to join this clinical trial?

"Yes, this trial is ongoing and actively recruiting patients as of today. The study was first posted on October 20th, 2021 with the most recent update occurring February 10th, 2022."

Answered by AI
~12 spots leftby Apr 2025